D-Index & Metrics Best Publications

Stephen J. Freedland

Cedars-Sinai Medical Center
United States

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 80 Citations 18,082 888 World Ranking 12095 National Ranking 6317

Research.com Recognitions

Awards & Achievements

2021 - Member of the American Society for Clinical Investigation

2020 - Member of the American Society for Clinical Investigation

2019 - Member of the American Society for Clinical Investigation

2018 - Member of the American Society for Clinical Investigation

2017 - Member of the American Society for Clinical Investigation

2016 - Member of the American Society for Clinical Investigation

2015 - Member of the American Society for Clinical Investigation

2014 - Member of the American Society for Clinical Investigation

2013 - Member of the American Society for Clinical Investigation

2012 - Member of the American Society for Clinical Investigation

2011 - Member of the American Society for Clinical Investigation

2010 - Member of the American Society for Clinical Investigation

2009 - Member of the American Society for Clinical Investigation

2008 - Member of the American Society for Clinical Investigation

2007 - Member of the American Society for Clinical Investigation

2006 - Member of the American Society for Clinical Investigation

2005 - Member of the American Society for Clinical Investigation

2004 - Member of the American Society for Clinical Investigation

2003 - Member of the American Society for Clinical Investigation

2002 - Member of the American Society for Clinical Investigation

2001 - Member of the American Society for Clinical Investigation

2000 - Member of the American Society for Clinical Investigation

1999 - Member of the American Society for Clinical Investigation

1998 - Member of the American Society for Clinical Investigation

1997 - Member of the American Society for Clinical Investigation

1996 - Member of the American Society for Clinical Investigation

1995 - Member of the American Society for Clinical Investigation

1994 - Member of the American Society for Clinical Investigation

1993 - Member of the American Society for Clinical Investigation

1992 - Member of the American Society for Clinical Investigation

1991 - Member of the American Society for Clinical Investigation

1990 - Member of the American Society for Clinical Investigation

1989 - Member of the American Society for Clinical Investigation

1988 - Member of the American Society for Clinical Investigation

1987 - Member of the American Society for Clinical Investigation

1986 - Member of the American Society for Clinical Investigation

1985 - Member of the American Society for Clinical Investigation

1984 - Member of the American Society for Clinical Investigation

1983 - Member of the American Society for Clinical Investigation

1982 - Member of the American Society for Clinical Investigation

Overview

What is he best known for?

The fields of study he is best known for:

Internal medicine
Cancer
Prostate cancer

Stephen J. Freedland mainly investigates Prostate cancer, Internal medicine, Oncology, Prostate-specific antigen and Prostatectomy. He interconnects Body mass index, Prostate and Gynecology in the investigation of issues within Prostate cancer. His Internal medicine research incorporates themes from Endocrinology and Surgery.

His Oncology study incorporates themes from Meta-analysis, Androgen deprivation therapy, Hormonal therapy and Radiation therapy. His work deals with themes such as Urology, Dutasteride, Guideline, Biopsy and Risk factor, which intersect with Prostate-specific antigen. His study looks at the intersection of Prostatectomy and topics like Cohort with PSA Failure.

His most cited work include:

The Molecular Taxonomy of Primary Prostate Cancer (1426 citations)
Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. (819 citations)
Early detection of prostate cancer: AUA Guideline (797 citations)

What are the main themes of his work throughout his whole career to date?

Stephen J. Freedland mostly deals with Prostate cancer, Internal medicine, Oncology, Prostatectomy and Prostate-specific antigen. His Prostate cancer study is associated with Cancer. Many of his studies involve connections with topics such as Endocrinology and Internal medicine.

The various areas that Stephen J. Freedland examines in his Oncology study include Obesity, Randomized controlled trial, Castration resistant, Metastasis and Radiation therapy. In general Prostatectomy study, his work on Biochemical recurrence often relates to the realm of Database, thereby connecting several areas of interest. His Prostate-specific antigen study integrates concerns from other disciplines, such as Body mass index, Odds ratio, Nephrology, Retrospective cohort study and Risk factor.

He most often published in these fields:

Prostate cancer (106.16%)
Internal medicine (92.66%)
Oncology (60.34%)

What were the highlights of his more recent work (between 2017-2021)?

Prostate cancer (106.16%)
Internal medicine (92.66%)
Oncology (60.34%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Prostate cancer, Internal medicine, Oncology, Prostatectomy and Prostate. The study incorporates disciplines such as Biopsy, Metastasis, Proportional hazards model and Cohort in addition to Prostate cancer. As a part of the same scientific study, Stephen J. Freedland usually deals with the Proportional hazards model, concentrating on Body mass index and frequently concerns with Obesity.

He combines subjects such as Castration resistant, Enzalutamide, Randomized controlled trial and MEDLINE with his study of Oncology. His work in the fields of Prostatectomy, such as Biochemical recurrence, overlaps with other areas such as Database. His work investigates the relationship between Prostate and topics such as Cancer research that intersect with problems in Gene and Androgen receptor.

Between 2017 and 2021, his most popular works were:

Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology. (153 citations)
Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology. (153 citations)
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options (128 citations)

In his most recent research, the most cited papers focused on:

Internal medicine
Cancer
Disease

Stephen J. Freedland focuses on Prostate cancer, Internal medicine, Oncology, Prostatectomy and Prostate. His Prostate cancer research is included under the broader classification of Cancer. Internal medicine and MEDLINE are commonly linked in his work.

In the subject of general Prostatectomy, his work in Biochemical recurrence is often linked to Database, thereby combining diverse domains of study. His studies deal with areas such as Cancer research, Gastroenterology, Cholesterol, High cholesterol and Prospective cohort study as well as Prostate. His Prostate biopsy research focuses on Prostate-specific antigen and how it connects with Body mass index, Urology and Obesity.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The Molecular Taxonomy of Primary Prostate Cancer

Adam Abeshouse;Jaeil Ahn;Rehan Akbani;Adrian Ally.
Cell (2015)

1968 Citations

Early detection of prostate cancer: AUA Guideline

H. Ballentine Carter;Peter C. Albertsen;Michael J. Barry;Ruth Etzioni.
The Journal of Urology (2013)

1212 Citations

Autonomic nerve development contributes to prostate cancer progression.

Claire Magnon;Simon J. Hall;Juan Lin;Xiaonan Xue.
Science (2013)

793 Citations

Prostate Cancer–Specific Survival Following Salvage Radiotherapy vs Observation in Men With Biochemical Recurrence After Radical Prostatectomy

Bruce J. Trock;Misop Han;Stephen J. Freedland;Elizabeth B. Humphreys.
JAMA (2008)

709 Citations

Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options

Martin G. Sanda;Jeffrey A. Cadeddu;Erin Kirkby;Ronald C. Chen.
The Journal of Urology (2018)

692 Citations

Active Surveillance for Prostate Cancer: A Systematic Review of the Literature

Marc A. Dall’Era;Peter C. Albertsen;Christopher Bangma;Peter R. Carroll.
European Urology (2012)

663 Citations

Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer

Nancy L. Keating;A. James O'Malley;Stephen J. Freedland;Matthew R. Smith.
Journal of the National Cancer Institute (2010)

575 Citations

Impact of Obesity on Biochemical Control After Radical Prostatectomy for Clinically Localized Prostate Cancer: A Report by the Shared Equal Access Regional Cancer Hospital Database Study Group

Stephen J. Freedland;William J. Aronson;Christopher J. Kane;Joseph C. Presti.
Journal of Clinical Oncology (2004)

535 Citations

Obesity and Prostate Cancer: Weighing the Evidence

Emma H. Allott;Elizabeth M. Masko;Stephen J. Freedland.
European Urology (2013)

485 Citations

Risk of Prostate Cancer-Specific Mortality Following Biochemical Recurrence After Radical Prostatectomy

Stephen J. Freedland;Elizabeth B. Humphreys;Leslie A. Mangold;Mario Eisenberger.
The Journal of Urology (2006)

463 Citations

If you think any of the details on this page are incorrect, let us know.